These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 24841163)

  • 1. Comparison of the efficacy of ciclesonide with that of budesonide in mild to moderate asthma patients after step-down therapy: a randomised parallel-group study.
    Chiu KC; Chou YL; Hsu JY; Lin MS; Lin CH; Chou PC; Chou CL; Wang CH; Kuo HP
    NPJ Prim Care Respir Med; 2014 May; 24():14010. PubMed ID: 24841163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ciclesonide is more effective than budesonide in the treatment of persistent asthma.
    Ukena D; Biberger C; Steinijans V; von Behren V; Malek R; Weber HH; Beck E; Linnhoff A
    Pulm Pharmacol Ther; 2007; 20(5):562-70. PubMed ID: 16962345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multinational, 12-week, randomized study comparing the efficacy and tolerability of ciclesonide and budesonide in patients with asthma.
    Hansel TT; Benezet O; Kafé H; Ponitz HH; Cheung D; Engelstätter R; Barnes PJ
    Clin Ther; 2006 Jun; 28(6):906-20. PubMed ID: 16860173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhaled ciclesonide versus inhaled budesonide or inhaled beclomethasone or inhaled fluticasone for chronic asthma in adults: a systematic review.
    Dyer MJ; Halpin DM; Stein K
    BMC Fam Pract; 2006 Jun; 7():34. PubMed ID: 16753053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Budesonide/formoterol maintenance and reliever therapy in primary care asthma management: effects on bronchial hyperresponsiveness and asthma control.
    Riemersma RA; Postma D; van der Molen T
    Prim Care Respir J; 2012 Mar; 21(1):50-6. PubMed ID: 22015542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of budesonide/formoterol pressurized metered-dose inhaler versus budesonide pressurized metered-dose inhaler alone in Hispanic adults and adolescents with asthma: a randomized, controlled trial.
    Zangrilli J; Mansfield LE; Uryniak T; O'Brien CD
    Ann Allergy Asthma Immunol; 2011 Sep; 107(3):258-65.e2. PubMed ID: 21875546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Step-down treatment from medium-dosage of budesonide/formoterol in controlled asthma.
    Mori K; Fujisawa T; Inui N; Hashimoto D; Enomoto N; Nakamura Y; Kuroishi S; Yokomura K; Toyoshima M; Imokawa S; Yamada T; Shirai T; Masuda M; Hayakawa H; Chida K; Suda T
    Respir Med; 2016 Oct; 119():1-6. PubMed ID: 27692128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the efficacy of ciclesonide 160 microg QD and budesonide 200 microg BID in adults with persistent asthma: a phase III, randomized, double-dummy, open-label study.
    Niphadkar P; Jagannath K; Joshi JM; Awad N; Boss H; Hellbardt S; Gadgil DA
    Clin Ther; 2005 Nov; 27(11):1752-63. PubMed ID: 16368446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of fluticasone/formoterol with budesonide/formoterol pMDI in adults with moderate to severe persistent asthma: Results from a 12-week randomized controlled trial.
    Balki A; Balamurugan S; Bardapurkar S; Dalal S; Singh A; Singh BP; Vaidya A; Gogtay JA
    Pulm Pharmacol Ther; 2018 Feb; 48():28-36. PubMed ID: 28890299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of different inhaled combination therapies (EDICT): a randomised, double-blind comparison of Seretide (50/250 microg bd Diskus vs. formoterol (12 microg bd) and budesonide (800 microg bd) given concurrently (both via Turbuhaler) in patients with moderate-to-severe asthma.
    Ringdal N; Chuchalin A; Chovan L; Tudoric N; Maggi E; Whitehead PJ;
    Respir Med; 2002 Nov; 96(11):851-61. PubMed ID: 12418582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of combination inhalers vs inhaled corticosteroids alone in moderate persistent asthma.
    Lee DK; Jackson CM; Currie GP; Cockburn WJ; Lipworth BJ
    Br J Clin Pharmacol; 2003 Nov; 56(5):494-500. PubMed ID: 14651722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The CONCEPT trial: a 1-year, multicenter, randomized,double-blind, double-dummy comparison of a stable dosing regimen of salmeterol/fluticasone propionate with an adjustable maintenance dosing regimen of formoterol/budesonide in adults with persistent asthma.
    FitzGerald JM; Boulet LP; Follows RM
    Clin Ther; 2005 Apr; 27(4):393-406. PubMed ID: 15922813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative efficacy of once-daily ciclesonide and budesonide in the treatment of persistent asthma.
    Boulet LP; Drollmann A; Magyar P; Timar M; Knight A; Engelstätter R; Fabbri L
    Respir Med; 2006 May; 100(5):785-94. PubMed ID: 16427266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review of efficacy of ciclesonide for the treatment of asthma in children.
    Blaiss M; Berger W; Chipps B; Hernandez-Trujillo V; Phipatanakul W; Steward K
    Allergy Asthma Proc; 2021 Nov; 42(6):461-470. PubMed ID: 34871153
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhaled Budesonide vis-à-vis Inhaled Mometasone in Chinese Children with Mild Persistent Asthma: A Single-Center, Retrospective Study.
    Gao P; Ding Y; Yin B; Gu H
    Pharmacology; 2021; 106(11-12):616-622. PubMed ID: 34518479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the efficacy and safety of ciclesonide 160 microg once daily vs. budesonide 400 microg once daily in children with asthma.
    von Berg A; Engelstätter R; Minic P; Sréckovic M; Garcia Garcia ML; Latoś T; Vermeulen JH; Leichtl S; Hellbardt S; Bethke TD
    Pediatr Allergy Immunol; 2007 Aug; 18(5):391-400. PubMed ID: 17617808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maintenance of asthma control by once-daily inhaled ciclesonide in adults with persistent asthma.
    Chapman KR; Patel P; D'Urzo AD; Alexander M; Mehra S; Oedekoven C; Engelstätter R; Boulet LP
    Allergy; 2005 Mar; 60(3):330-7. PubMed ID: 15679718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real-world effects of two inhaled corticosteroid/long-acting β₂-agonist combinations in the treatment of asthma.
    Yatera K; Yamasaki K; Nishida C; Noguchi S; Oda K; Akata K; Nagata S; Kawanami Y; Kawanami T; Ishimoto H; Mukae H
    J Asthma; 2014 Sep; 51(7):762-8. PubMed ID: 24654703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety evaluation of ciclesonide in mild-to-moderate persistent asthma previously treated with inhaled corticosteroids.
    Meltzer EO; Korenblat PE; Weinstein SF; Noonan M; Karafilidis J
    Allergy Asthma Proc; 2009; 30(3):293-303. PubMed ID: 19549431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EXCEL: A randomised trial comparing salmeterol/fluticasone propionate and formoterol/budesonide combinations in adults with persistent asthma.
    Dahl R; Chuchalin A; Gor D; Yoxall S; Sharma R
    Respir Med; 2006 Jul; 100(7):1152-62. PubMed ID: 16675212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.